The Access to Medicine Index (A): Engaging Stakeholders and Attracting Funding Net Present Value (NPV) / MBA Resources

Introduction to Net Present Value (NPV) - What is Net Present Value (NPV) ? How it impacts financial decisions regarding project management?

NPV solution for The Access to Medicine Index (A): Engaging Stakeholders and Attracting Funding case study

At Oak Spring University, we provide corporate level professional Net Present Value (NPV) case study solution. The Access to Medicine Index (A): Engaging Stakeholders and Attracting Funding case study is a Harvard Business School (HBR) case study written by Afshin Mehrpouya, Diane-Laure Arjalies, Ken Mark. The The Access to Medicine Index (A): Engaging Stakeholders and Attracting Funding (referred as “Atmi Medicine” from here on) case study provides evaluation & decision scenario in field of Leadership & Managing People. It also touches upon business topics such as - Value proposition, .

The net present value (NPV) of an investment proposal is the present value of the proposal’s net cash flows less the proposal’s initial cash outflow. If a project’s NPV is greater than or equal to zero, the project should be accepted.

NPV = Present Value of Future Cash Flows LESS Project’s Initial Investment

---

Case Description of The Access to Medicine Index (A): Engaging Stakeholders and Attracting Funding Case Study

The founder of the Access to Medicine Foundation, based in the Netherlands, had a goal to research and publish a biannual, global survey of pharmaceutical companies and their rankings, in terms of their effects in providing needed medicines to people in developing countries. When the first two iterations of the Access to Medicine Index (ATMI) were published in 2008 and 2010 (see case A), the most prominent challenges were engaging stakeholders-government, pharmaceutical firms, nonprofit organizations, investors, and others-and securing funding to support ongoing research and analyses. In 2016, the founder was preparing for the ATMI's fifth iteration (see case B, W17013), and he had a three-point focus: to improve engagement with pharmaceutical companies in an effort to increase the effect of the ATMI on companies' practices; to incorporate the views of patients into the ATMI; and to engage with governments and regulators in the developing countries, where citizens were in need of access to medicines.

Case Authors : Afshin Mehrpouya, Diane-Laure Arjalies, Ken Mark

Topic : Leadership & Managing People

Related Areas :

---

Calculating Net Present Value (NPV) at 6% for The Access to Medicine Index (A): Engaging Stakeholders and Attracting Funding Case Study

Years	Cash Flow	Net Cash Flow	Cumulative     Cash Flow	Discount Rate @ 6 %	Discounted Cash Flows
Year 0	(10016416)	-10016416	-	-
Year 1	3462337	-6554079	3462337	0.9434	3266356
Year 2	3973389	-2580690	7435726	0.89	3536302
Year 3	3959423	1378733	11395149	0.8396	3324408
Year 4	3244721	4623454	14639870	0.7921	2570123
TOTAL			14639870		12697189

The Net Present Value at 6% discount rate is 2680773

In isolation the NPV number doesn't mean much but put in right context then it is one of the best method to evaluate project returns. In this article we will cover -

Different methods of capital budgeting

What is NPV & Formula of NPV,
How it is calculated,
How to use NPV number for project evaluation, and
Scenario Planning given risks and management priorities.

---

Capital Budgeting Approaches

Methods of Capital Budgeting

There are four types of capital budgeting techniques that are widely used in the corporate world –

1. Profitability Index
2. Payback Period
3. Net Present Value
4. Internal Rate of Return

Apart from the Payback period method which is an additive method, rest of the methods are based on Discounted Cash Flow technique. Even though cash flow can be calculated based on the nature of the project, for the simplicity of the article we are assuming that all the expected cash flows are realized at the end of the year.

Discounted Cash Flow approaches provide a more objective basis for evaluating and selecting investment projects. They take into consideration both –

1. Timing of the expected cash flows – stockholders of Atmi Medicine have higher preference for cash returns over 4-5 years rather than 10-15 years given the nature of the volatility in the industry.
2. Magnitude of both incoming and outgoing cash flows – Projects can be capital intensive, time intensive, or both. Atmi Medicine shareholders have preference for diversified projects investment rather than prospective high income from a single capital intensive project.

---

Formula and Steps to Calculate Net Present Value (NPV) of The Access to Medicine Index (A): Engaging Stakeholders and Attracting Funding

NPV = Net Cash In Flowt1 / (1+r)t1 + Net Cash In Flowt2 / (1+r)t2 + … Net Cash In Flowtn / (1+r)tn
Less Net Cash Out Flowt0 / (1+r)t0

Where t = time period, in this case year 1, year 2 and so on.
r = discount rate or return that could be earned using other safe proposition such as fixed deposit or treasury bond rate. Net Cash In Flow – What the firm will get each year.
Net Cash Out Flow – What the firm needs to invest initially in the project.

Step 1 – Understand the nature of the project and calculate cash flow for each year.
Step 2 – Discount those cash flow based on the discount rate.
Step 3 – Add all the discounted cash flow.
Step 4 – Selection of the project

Why Leadership & Managing People Managers need to know Financial Tools such as Net Present Value (NPV)?

In our daily workplace we often come across people and colleagues who are just focused on their core competency and targets they have to deliver. For example marketing managers at Atmi Medicine often design programs whose objective is to drive brand awareness and customer reach. But how that 30 point increase in brand awareness or 10 point increase in customer touch points will result into shareholders’ value is not specified.

To overcome such scenarios managers at Atmi Medicine needs to not only know the financial aspect of project management but also needs to have tools to integrate them into part of the project development and monitoring plan.

Calculating Net Present Value (NPV) at 15%

After working through various assumptions we reached a conclusion that risk is far higher than 6%. In a reasonably stable industry with weak competition - 15% discount rate can be a good benchmark.

Years	Cash Flow	Net Cash Flow	Cumulative     Cash Flow	Discount Rate @ 15 %	Discounted Cash Flows
Year 0	(10016416)	-10016416	-	-
Year 1	3462337	-6554079	3462337	0.8696	3010728
Year 2	3973389	-2580690	7435726	0.7561	3004453
Year 3	3959423	1378733	11395149	0.6575	2603385
Year 4	3244721	4623454	14639870	0.5718	1855180
TOTAL					10473745

The Net NPV after 4 years is 457329

(10473745 - 10016416 )

---

Calculating Net Present Value (NPV) at 20%

If the risk component is high in the industry then we should go for a higher hurdle rate / discount rate of 20%.

Years	Cash Flow	Net Cash Flow	Cumulative     Cash Flow	Discount Rate @ 20 %	Discounted Cash Flows
Year 0	(10016416)	-10016416	-	-
Year 1	3462337	-6554079	3462337	0.8333	2885281
Year 2	3973389	-2580690	7435726	0.6944	2759298
Year 3	3959423	1378733	11395149	0.5787	2291333
Year 4	3244721	4623454	14639870	0.4823	1564777
TOTAL					9500688

The Net NPV after 4 years is -515728

At 20% discount rate the NPV is negative (9500688 - 10016416 ) so ideally we can't select the project if macro and micro factors don't allow financial managers of Atmi Medicine to discount cash flow at lower discount rates such as 15%.

Acceptance Criteria of a Project based on NPV

Simplest Approach – If the investment project of Atmi Medicine has a NPV value higher than Zero then finance managers at Atmi Medicine can ACCEPT the project, otherwise they can reject the project. This means that project will deliver higher returns over the period of time than any alternate investment strategy.

In theory if the required rate of return or discount rate is chosen correctly by finance managers at Atmi Medicine, then the stock price of the Atmi Medicine should change by same amount of the NPV. In real world we know that share price also reflects various other factors that can be related to both macro and micro environment.

In the same vein – accepting the project with zero NPV should result in stagnant share price. Finance managers use discount rates as a measure of risk components in the project execution process.

Sensitivity Analysis

Project selection is often a far more complex decision than just choosing it based on the NPV number. Finance managers at Atmi Medicine should conduct a sensitivity analysis to better understand not only the inherent risk of the projects but also how those risks can be either factored in or mitigated during the project execution. Sensitivity analysis helps in –

What are the key aspects of the projects that need to be monitored, refined, and retuned for continuous delivery of projected cash flows.

What will be a multi year spillover effect of various taxation regulations.

Understanding of risks involved in the project.

What can impact the cash flow of the project.

What are the uncertainties surrounding the project Initial Cash Outlay (ICO’s). ICO’s often have several different components such as land, machinery, building, and other equipment.

Some of the assumptions while using the Discounted Cash Flow Methods –

Projects are assumed to be Mutually Exclusive – This is seldom the came in modern day giant organizations where projects are often inter-related and rejecting a project solely based on NPV can result in sunk cost from a related project.

Independent projects have independent cash flows – As explained in the marketing project – though the project may look independent but in reality it is not as the brand awareness project can be closely associated with the spending on sales promotions and product specific advertising.

---

Negotiation Strategy of The Access to Medicine Index (A): Engaging Stakeholders and Attracting Funding

References & Further Readings

Afshin Mehrpouya, Diane-Laure Arjalies, Ken Mark (2018), "The Access to Medicine Index (A): Engaging Stakeholders and Attracting Funding Harvard Business Review Case Study. Published by HBR Publications.